Synapse Open Synapse
Biology

Selectively disrupting lysine acetyltransferase p300 and ZEB1 interaction prevents tumor progression while enhancing antitumor immunity

PNAS ·

Proceedings of the National Academy of Sciences, Volume 123, Issue 46, November 2026. SignificanceSelectively disrupting lysine acetyltransferase p300 interaction with specific pro-oncogenic targets serves as a safe and effective strategy for cancer treatment.

Latest from PNAS